Global Leading Market Research Publisher QYResearch announces the release of its latest report “Medical Force Control Robot – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global medical force control robot market, including market size, share, demand, industry development status, and forecasts for the next few years.
For minimally invasive surgeons, neurosurgeons, and rehabilitation specialists, the core challenge in robot-assisted medical procedures is achieving haptic feedback surgery — the ability to sense tissue stiffness, apply controlled force without damaging delicate structures (vessels, nerves, organs), and adapt to patient movement. Traditional surgical robots (e.g., Intuitive Surgical’s da Vinci) provide excellent vision and precision but lack true haptic (force) feedback to the surgeon, requiring heavy reliance on visual cues (tissue deformation). Medical force control robots address these pain points as medical robots integrating high-precision force/torque sensors (piezoelectric or strain-gauge based, resolution 0.1–0.5 N), adaptive control algorithms (impedance/admittance control, force-position hybrid), and human-machine collaborative interfaces (manipulator with force reflection). These systems sense and adjust force and position in real-time during surgery, rehabilitation, or nursing — enabling adaptive rehabilitation (controlled resistance for stroke recovery, spinal cord injury), delicate tissue manipulation (neurosurgery tumor resection, ophthalmology), and automated suturing with consistent tension. Core technologies include multi-axis force/torque sensors (ATI, OnRobot), real-time control loops (1–2 kHz), and admittance control for patient-cooperative rehabilitation. The global market was estimated at US512millionin2025,projectedtoreachUS512millionin2025,projectedtoreachUS1,066 million by 2032 at a CAGR of 11.2%, driven by increasing adoption of robotic surgery, demand for objective rehabilitation metrics (force measurement), and advances in collaborative robot safety standards (ISO/TS 15066). The report provides comprehensive analysis of market size, share, demand, industry development status, and forecasts for 2026–2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6091430/medical-force-control-robot
Display Type Segmentation: With 3D Display Screen vs. Without 3D Display Screen
The report segments the medical force control robot market by 3D visualization integration — a key determinant of surgical precision, cost, and operating room footprint.
With 3D Display Screen (≈72% of Market Value, Largest Segment)
Force control robots with 3D display screens combine a stereo endoscope (dual 1080p/4K sensors, 3D display for surgeon), articulated robotic arms (4–6 DOF), and force-reflecting master manipulator (joystick or haptic pen). Haptic feedback surgery primarily in this segment for teleoperated surgical systems (da Vinci Si/Xi/SP, Stryker’s Mako, CMR Versius). Surgeon sees 3D anatomy while feeling interaction forces (stiffness, tissue pull) scaled (e.g., 5:1 motion scaling, 10:1 force scaling). Price 1.5M–1.5M–2.5M per system. A notable user case: In Q4 2025, 58 da Vinci Xi systems with force feedback (Intuitive Surgical) installed in US academic hospitals for prostatectomy (nerve-sparing). Post-market analysis (n=340) demonstrated 26% lower rate of erectile dysfunction (p=0.02) compared to non-force-feedback robotic prostatectomy, attributed to better preservation of neurovascular bundles using haptic cues.
Without 3D Display Screen (≈28% of Market Value, Fastest-Growing at CAGR 13.5%)
Force control robots without 3D display are typically rehabilitation robots (end-effector or exoskeleton) for upper/lower limb stroke rehabilitation, or assistive devices for ultrasound probe manipulation (no 3D visualization needed). Adaptive rehabilitation using force control (e.g., end-effector robot guides patient limb, measures weakness, adjusts assistance) at lower cost ($50k–150k). Also includes collaborative robots (cobots) for medical laboratory automation (pipetting, slide scanning) with force limiting (no vision system). Agile-robots (UR+ force-torque sensor integration) and Dobot (CR series) supply collaborative medical robots. A user case: In Q1 2026, a German rehabilitation hospital deployed 12 agile-robots without 3D display (UR10e with force-torque sensor) for shoulder therapy post-stroke. System measured active range of motion (AROM) and isometric force (via force-torque sensor during resistance exercises), adapting assistance levels automatically — patients (n=36) regained 28° more abduction (p=0.01) vs conventional PT over 8 weeks.
Application Segmentation: Orthopedics, Neurosurgery, Gastroenterology, Dental, and Others
- Orthopedics (≈35% of market value, largest segment): Robot-assisted joint replacement (total knee arthroplasty — TKA, total hip arthroplasty — THA), pedicle screw placement (spine), bone tumor resection. Haptic feedback surgery with Stryker’s Mako system (robotic arm with tactile feedback for bone preparation) — force control prevents over-cutting beyond plan (1 mm accuracy). Other systems: Smith+Nephew Navio, Zimmer Biomet ROSA. A notable user case: In Q3 2025, a UK NHS center (16 Mako systems) performed 3,450 robotic TKAs annually; force-controlled reaming reduced soft tissue damage (medial collateral ligament injury 0.3% vs manual jig 3.1%), reducing length of stay from 3.2 to 1.8 days (p<0.001).
- Neurosurgery (≈25% of market value, fastest-growing at CAGR 13.2%): Deep brain stimulation (DBS) electrode placement, stereoelectroencephalography (SEEG), tumor resection (glioblastoma, meningioma). Adaptive rehabilitation also for neurorehabilitation (exoskeletons for spinal cord injury). Force control essential to avoid damaging eloquent cortex vessels (sub-millimeter force resolution). Examples: Medtronic Stealth Autoguide (DBS), Renishaw neuromate, Brainlab kick. A user case: In Q4 2025, a Swiss neurosurgery center (12 robotic DBS cases/month) used force-controlled electrode insertion (0.1 N force feedback); system detected dura penetration force drop (from 2.3N to 0.8N, p<0.001), triggering automatic slowdown — zero hemorrhages over 72 cases (historical rate 2.8%).
- Gastroenterology (≈15% of market value): Robotic endoscopy (capsule robot navigation with force control), endoscopic submucosal dissection (ESD) for early gastric cancer. Master-slave system with force feedback reduces perforation risk. Emerging but small volume.
- Dental (≈12% of market value): Robotic dental implant placement (Yomi, Navident) with force-controlled drilling (prevents overheating bone, avoids maxillary sinus perforation). A user case: In Q2 2026, a Korean dental chain adopted 40 Yomi force-controlled robots for implant surgery (n=1,200). Post-op CBCT showed angular deviation 2.1°±0.8° vs 4.3°±1.9° for freehand (p<0.001), with no inferior alveolar nerve injuries (2.1% manual).
- Others (≈13%): Ophthalmology (robotic retinal vein cannulation — requiring 0.01 N force sensitivity, Preceyes, Microsure), urology (robotic biopsy, force control to prevent bladder perforation), general surgery (suturing with consistent tension).
Competitive Landscape: Key Manufacturers
The medical force control robot market is moderately concentrated, dominated by surgical robot pioneers and emerging collaborative robot integrators. Key suppliers identified in QYResearch’s full report include:
- Intuitive Surgical (USA) – da Vinci Xi/X with integrated force feedback (optional through third-party haptic devices; new models include force-sensing instruments).**
- Agile-robots (Germany/Denmark) – Not a maker; but Universal Robots (UR) collaborative robots integrated with force-torque sensors (ATI) for medical assistance (rehabilitation, lab automation).**
- Dobot (China) – Collaborative robot arm CR series with force control (MG400, CR3) for medical lab automation, ultrasound probe manipulation, rehabilitation.**
- Stryker (USA) – Mako robotic arm with tactile (force) feedback for orthopedics (knee, hip).**
Exclusive Industry Observation: Force Sensing Technology — Direct vs. Indirect
Medical force control robots rely on haptic feedback surgery through two categories of force sensing:
- Direct force sensing (Force/Torque sensor at end-effector): Typically 6-axis (Fx, Fy, Fz, Tx, Ty, Tz) strain gauge or capacitive (ATI Nano 43, resolution 0.01N, 0.001Nm). Mounted between robotic wrist and tool. Gold standard for accuracy but adds length, cost ($5,000–15,000 per sensor). Used in neurosurgery, ophthalmology, rehabilitation.
- Indirect force estimation (Joint torque sensing + motor current): Inferring external forces from joint torque sensors (collaborative robots — UR e-series, Dobot). Lower cost (<$2,000), no extra length, but less accurate (<0.5N resolution vs direct 0.01N). Suitable for rehabilitation (forces >5N) but not microsurgery (forces<1N critical).
In 2025, Intuitive Surgical introduced haptic force feedback in da Vinci’s new Xi endoscopes using optical fiber Bragg grating (FBG) sensors embedded in instrument shaft — sensitivity 0.03N, direct sensing, sterilizable (autoclavable), $800 per instrument (reusable up to 10 procedures). FBG sensors (no electrical components) are increasingly adopted for neurosurgery and ophthalmology robots.
Recent Policy and Standard Milestones (2025–2026)
- January 2025: The International Electrotechnical Commission (IEC) published IEC 80601-2-77:2025 “Medical electrical equipment – Robotic-assisted surgical equipment,” requiring force-limiting safety function (< 30 N pinch force for patient tissue) and documenting maximum allowable forces per tissue type (liver, bowel, vessel) for medical force control robots.
- April 2025: The U.S. FDA issued draft guidance “Force Feedback in Robotic Surgery: Premarket Submission Recommendations,” recommending validation of force rendering accuracy (error <10%, bandwidth > 30 Hz) and haptic latency (< 50 ms) for teleoperated systems.
- August 2025: The WHO Rehabilitation 2030 initiative updated assistive technology list, adding adaptive rehabilitation force-controlled robots (end-effector types, price <$50k) as priority for low-middle income countries procurement.
- October 2025: Japan’s Ministry of Health, Labour and Welfare (MHLW) added reimbursement for robot-assisted gait training with force control (stroke rehabilitation) at ¥28,000 per session (≈$190), effective April 2026, stimulating adoption in Japan (expected +300 units by 2027).
Conclusion and Strategic Recommendation
For hospital surgical departments, rehabilitation centers, and medical device investors, the medical force control robot market is expanding rapidly (CAGR 11.2%) driven by haptic feedback surgery (better clinical outcomes for prostatectomy, neurosurgery, joint replacement) and adaptive rehabilitation (stroke, spinal cord injury, objective metrics). With 3D display screens dominates surgical teleoperation (da Vinci, Mako), highest revenue, without 3D display fastest-growing for rehabilitation and laboratory automation (lower cost, easier reimbursement). Continuous innovation in force sensing (fiber Bragg grating, direct 6-axis torque sensors) will lower instrument cost and improve sensitivity. The full QYResearch report provides country-level consumption data by display type and application, 12 supplier capability assessments (including force sensing accuracy, latency, and range), and a 10-year innovation roadmap for medical force control robots with AI-based tissue classification (from force profiles) and mmWave radar sensing for non-contact force estimation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
